CIK 0001527728 · Non-accelerated filer<br>Smaller reporting company
Lunai Bioworks Inc.
Sign in to watch- Ticker
- LNAI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452259340
- Phone
- 45 39179840
- Business address
- CENTURY CITY MEDICAL PLAZA, 2080 CENTURY CITY EAST, SUITE 906 LOS ANGELES, CA, 90067
- Former names
- RENOVARO INC., RENOVARO BIOSCIENCES INC., Enochian Biosciences Inc, DanDrit Biotech USA, Inc., Putnam Hills Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-22 | Sindlev Rene Director | Grant or award · Option to purchase shares of common stock | +3,646 | 3,646 | ||
| 2021-12-16 | Puche Luisa Chief Financial Officer | Returned to the company | −10,000 | 0 | ||
| 2021-12-16 | Puche Luisa Chief Financial Officer | Grant or award | +16,266 | 16,266 | ||
| 2021-12-16 | Puche Luisa Chief Financial Officer | Grant or award · Restricted Stock Units | +16,266 | $7.75 | $126K | 16,266 |
| 2021-10-26 | Puche Luisa Chief Financial Officer | Grant or award · Option to purchase shares of common stock | +60,000 | 60,000 | ||
| 2021-10-11 | Gronfeldt-Sorensen Henrik Director | Grant or award · Option to purchase shares of common stock | +10,519 | 10,519 | ||
| 2021-10-11 | Gronfeldt-Sorensen Henrik Director | Grant or award · Option to purchase shares of common stock | +10,519 | 10,519 | ||
| 2021-07-28 | Sindlev Rene Director | Grant or award · Option to purchase shares of common stock | +9,036 | 9,036 | ||
| 2021-07-19 | Dybul Mark Chief Executive Officer | Grant or award · Option to purchase shares of common stock | +2,000,000 | 2,000,000 | ||
| 2021-06-24 | McNicol Jayne Director | Grant or award · Option to purchase shares of common stock | +26,498 | 26,498 | ||
| 2021-03-06 | D An Evelyn Director | Grant or award · Option to Purchase Common Stock | +19,894 | 19,894 | ||
| 2021-03-06 | SAPIRSTEIN JAMES Director | Grant or award · Option to Purchase Common Stock | +19,894 | 19,894 | ||
| 2021-02-28 | Sandler Carl Forest Jr Director | Grant or award · Option to purchase shares of common stock | +12,712 | 12,712 | ||
| 2020-12-28 | Alton Gregg H Director | Grant or award · Option to purchase shares of common stock | +25,424 | 25,424 | ||
| 2020-12-28 | Brosgart Carol L Director | Grant or award · Option to purchase shares of common stock | +25,424 | 25,424 | ||
| 2020-12-14 | Weird Science LLC 10% owner | Other acquisition | +61,249 | 4,961,363 | ||
| 2020-12-14 | Dybul Mark Executive Vice Chair | Other acquisition | +180 | 66,196 | ||
| 2020-12-14 | Sandler Carl Forest Jr Director | Other acquisition | +61,249 | 4,961,363 | ||
| 2020-06-11 | Dybul Mark Executive Vice Chair | Grant or award · Option to Purchase Common Stock | +450,000 | 450,000 | ||
| 2020-05-29 | Weird Science LLC 10% owner | Other disposition | −17,545,283 | 4,900,114 |
Page 7 of 10 · 198 trades